Strategy Inc. Form 8-K Summary
Business Context and Reporting Period
Company: Strategy Inc.
Filing Date: November 4, 2025
Reporting Period: Current Report (Event Date: November 4, 2025)
Event: Consolidation of existing at-the-market (ATM) offering programs into a single Omnibus Sales Agreement to improve administrative efficiency.
Key Financial Metrics and Capital Structure
This filing details the authorization to sell specific securities rather than reporting operational financial results (revenue, profit, or cash flow). The filing does not provide current revenue, profit, or liquidity metrics.
Authorized Offering Amounts (Remaining Unsold from Prior Agreements):
- STRF Stock (10.00% Series A Perpetual Strife Preferred): Up to $1,659,967,526.88
- STRC Stock (Variable Rate Series A Perpetual Stretch Preferred): Up to $4,200,000,000.00
- STRK Stock (8.00% Series A Perpetual Strike Preferred): Up to $20,340,632,356.64
- STRD Stock (10.00% Series A Perpetual Stride Preferred): Up to $4,133,799,112.67
- Common Stock (Class A): Up to $15,854,365,265.54
- Total Aggregate Offering Capacity: Approximately $46.19 billion
Transaction Costs: The Company agreed to pay sales agents commissions of up to 2.0% of aggregate gross proceeds.
Material Changes Versus Prior Period
The Company terminated five separate "Prior Sales Agreements" dated between March 1, 2025, and July 31, 2025, and replaced them with a single "Omnibus Sales Agreement."
- Consolidation: All prior ATM programs were merged to streamline administration.
- Continuity: The aggregate offering amounts under the new agreement equal the unsold amounts remaining under the terminated agreements.
- Agents: The new agreement engages a broad syndicate of 15 sales agents, including TD Securities, Barclays, Morgan Stanley, and Mizuho Securities.
Guidance, Outlook, and Risks
Management Commentary: The consolidation is intended to enable greater efficiency in administering existing and potential future ATM offerings. The Company retains discretion over the timing, amount, and class of shares sold.
Outlook: No assurance is given that the Company will sell any shares under the new agreement. Sales are subject to market conditions and the Company's determination.
Risks and Contingencies:
- Market Risk: Actual results may differ materially due to market conditions and uncertainties related to sales execution.
- Dilution: Future sales of Common Stock or Preferred Stock may dilute existing shareholders.
- Forward-Looking Statements: The filing disclaims any obligation to update forward-looking statements regarding the Offering.
Investor Verification Checklist
- Verify Unsold Capacity: Confirm the exact remaining unsold amounts for each security class as of the filing date to understand potential dilution.
- Review Prospectus Supplements: Examine the Base Prospectus Supplement and Annexes for specific terms of the preferred stock series (STRF, STRC, STRK, STRD).
- Monitor Sales Activity: Track future 8-K filings or Form 4 submissions to determine if and when the Company elects to sell shares under the new Omnibus Agreement.
- Assess Liquidity Needs: Evaluate the Company's recent cash flow statements (from the November 3, 2025, 10-Q) to gauge the urgency of utilizing this $46.19 billion capacity.